Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Reductions in vascular density occur following acute ischemia-reperfusion (I/R) injury that may predispose the development of chronic kidney disease. The mechanisms mediating vascular loss are not clear but may relate to the lack of effective vascular repair responses. To determine the regulation of the VEGF/VEGFR pathway following I/R injury, male Sprague-Dawley rats were subjected to bilateral renal ischemia (45 min) and allowed to recover for 1, 3, 7, and 35 days. VEGF mRNA expression was repressed by greater than 50% of control values up to 3 days postischemia, while VEGF protein was repressed for up to 7 days postischemia. The renal mRNA expression of receptors was not altered postischemia; however, VEGFR1 (flt-1) protein was transiently reduced in kidney while soluble flt-1 was elevated in plasma at 7 days following injury. Microarray analysis of angiogenesis-related genes identified the enhanced expression of a number of genes, among these was ADAMTS-1 (a disintegrin and metalloproteinase with thrombospondin motif-1), a secreted VEGF inhibitor. The altered expression of ADAMTS-1 was confirmed using RT-PCR and Western blot analysis; immunofluorescence localized its expression to proximal tubules following I/R injury. Other genes identified using microarray included aminopeptidase N, Smad-1, and Id-3 and their localization was also examined using immunohistochemistry. In summary, the data indicate no clear pattern of anti-angiogenic gene expression following renal I/R injury. However, the studies do suggest an overall inhibition of the VEGF pathway during the early injury and repair phase of renal ischemia that may contribute to an overall reduction in renal microvascular density.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101 · cited 1×
“Its elevation in plasma was reported in patients with preeclampsia and has been reported in models of chronic kidney disease and hypertension (16, 19).”
BackgroundEndothelial cells and VEGF in vascular development
Coultas, L., Chawengsaksophak, K., & Rossant, J. (2005) · Nature · doi:10.1038/nature04479 · Cited by 1,016 · cited 1×
“The soluble form of the flt-1 receptor results from the differential splicing of mRNA and is thought to act as a competitive inhibitor of VEGF thereby reducing its bioavailability (10).”
Background
Cited by
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Cellular pathophysiology of ischemic acute kidney injury
Bonventre, J. V., & Yang, L. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45161 · Cited by 2,019
Humphreys, B. D. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034227 · Cited by 1,231
Pathophysiology of Acute Kidney Injury
Basile, D. P., Anderson, M. D., & Sutton, T. A. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110041 · Cited by 1,094
Self-citationPathophysiology of ischemic acute kidney injury
Sharfuddin, A. A., & Molitoris, B. A. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.16 · Cited by 796
Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression
Venkatachalam, M. A., Weinberg, J. M., Kriz, W., & Bidani, A. K. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015010006 · Cited by 744
AKI in the ICU: definition, epidemiology, risk stratification, and outcomes
Singbartl, K., & Kellum, J. A. (2012) · Kidney International · doi:10.1038/ki.2011.339 · Cited by 563
Acute kidney injury: a springboard for progression in chronic kidney disease
Venkatachalam, M. A., Griffin, K. A., Lan, R., Geng, H., Saikumar, P., & Bidani, A. K. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00017.2010 · Cited by 519
Cellular and molecular mechanisms of kidney fibrosis
Djudjaj, S., & Boor, P. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.06.002 · Cited by 475
Basile, D. P., Friedrich, J. L., Spahic, J., Knipe, N., Mang, H., Leonard, E. C., Changizi-Ashtiyani, S., Bacallao, R. L., Molitoris, B. A., & Sutton, T. A. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00546.2010 · Cited by 296
Self-citationHypoxia as a key player in the AKI-to-CKD transition
Tanaka, S., Tanaka, T., & Nangaku, M. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00425.2014 · Cited by 280
Cellular and molecular pathways of renal repair after acute kidney injury
Kumar, S. (2018) · Kidney International · doi:10.1016/j.kint.2017.07.030 · Cited by 271
ADAMTS proteoglycanases in the physiological and pathological central nervous system.
Lemarchant, S., Pruvost, M., Montaner, J., Emery, E., Vivien, D., Kanninen, K., & Koistinaho, J. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-133 · Cited by 96
“Both proteinase-dependent and independent antiangiogenic functions for most of the ADAMTS proteases, including proteoglycanases, have been described [42-45].”
BackgroundBespalova, I. N., Angelo, G. W., Ritter, B. P., Hunter, J., Reyes-Rabanillo, M. L., Siever, L. J., & Silverman, J. M. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8169-y · Cited by 14
“…proposed to be involved in neuroinflammatory responses (Rosenberg 2009b), early development and reproduction (Shindo et al. 2010; Tang 2001), cartilage metabolism (Jones and Riley 2005; Tortorella and Malfait 2008; Bondeson et al. 2008), and angiogenesis (Vázquez et al. 1999; Basile et al. 2008).”
Background
Metadata
- Authors
- Basile, D. P., Fredrich, K., Chelladurai, B., Leonard, E. C., & Parrish, A. R.
- Venue
- American Journal of Physiology-Renal Physiology
- Publisher
- American Physiological Society
- Published
- 2008-04
- Volume
- 294
- Issue
- 4
- Pages
- F928-F936
- ISSN
- 1522-1466 (ISSN-L)
- 1931-857X
- OpenAlex
- W2158646897
- Cited by
- 177
- References
- 3
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.